Kodiak Sciences Inc. KOD
99.10 USD +0.21 (+0.21%)
Nov 4, 2026, 10:10 AM EST
99.22 Day range 101.92
15.83 52-week range 104.00
- YTD
- +254.44%
- 1 year
- +447.52%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 121.67 +22.8% upside
Now 99.10
- Target (low)
- 103.00
- Target (mean)
- 121.67
- Target (high)
- 145.00
Ratings (0m) 7 6 buy · 1 hold · 0 sell
- Strong buy1
- Buy5
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 7
- 1 month ago 7
- 2 months ago 6
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -1.01 | -1.10 – -0.89 | -1.16 | +12.9% | 0 | 0.0% | 5 |
| Next quarter | -0.98431 | -1.11 – -0.89 | -1.04 | +5.3% | 0 | 0.0% | 5 |
| Current year | -3.98 | -4.20 – -3.75 | -4.32 | +7.8% | 0 | 0.0% | 5 |
| Next year | -3.44 | -4.92 – -1.99 | -3.98 | +13.7% | 49.14M | 0.0% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 12, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Sep 28, 2026 | LifeSci Capital | Maintained | Outperform | Outperform |
| Sep 28, 2026 | UBS | Maintained | Buy | Buy |
| Sep 28, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Sep 17, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 17, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 3, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| May 11, 2026 | Chardan Capital | Upgrade | Neutral | Buy |
| Mar 27, 2026 | UBS | Maintained | Buy | Buy |
| Mar 27, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Feb 10, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jan 22, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jan 7, 2026 | UBS | Initiated | — | Buy |
| Nov 17, 2025 | Chardan Capital | Maintained | Neutral | Neutral |
| Nov 17, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Nov 11, 2025 | HC Wainwright & Co. | Upgrade | Neutral | Buy |
| Oct 24, 2025 | JP Morgan | Upgrade | Neutral | Overweight |
| Oct 23, 2025 | LifeSci Capital | Initiated | — | Outperform |
| Oct 6, 2025 | Chardan Capital | Maintained | Neutral | Neutral |
| Sep 25, 2025 | Barclays | Upgrade | Underweight | Equal-Weight |
| Sep 22, 2025 | Jefferies | Initiated | — | Buy |
| Aug 18, 2025 | HC Wainwright & Co. | Maintained | Neutral | Neutral |
| Aug 14, 2025 | Barclays | Maintained | Underweight | Underweight |
| Aug 14, 2025 | JP Morgan | Upgrade | Underweight | Neutral |
| Mar 31, 2025 | HC Wainwright & Co. | Reiterated | Neutral | Neutral |
| Dec 9, 2024 | Jefferies | Upgrade | Hold | Buy |
| Nov 15, 2024 | Barclays | Maintained | Underweight | Underweight |
| Nov 15, 2024 | HC Wainwright & Co. | Reiterated | Neutral | Neutral |
| Sep 24, 2024 | HC Wainwright & Co. | Reiterated | Neutral | Neutral |
| Sep 5, 2024 | HC Wainwright & Co. | Initiated | — | Neutral |